CariƱo, Mae-ann R.
HRN: 22-68-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2023
CEFUROXIME 1.5GM (VIAL)
03/25/2023
03/27/2023
IV
1.5 G
Q8 X 3 More Doses
SP CS With IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes